reference/35798711

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35798711

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1465-542X
issueIdentifier	1
pageRange	34-
publicationName	Breast cancer research : BCR
startingPage	34
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8b600fd0a0201548c882a3a5f3e4155b
bibliographicCitation	Hu XE, Yang P, Chen S, Wei G, Yuan L, Yang Z, Gong L, He L, Yang L, Peng S, Dong Y, He X, Bao G. Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low. Breast Cancer Res. 2023 Mar 30;25(1):34. PMID: 36998014; PMCID: PMC10061837.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1871d82540f8ca48fdf5896f91d7983 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff2d1d76a71c900230b59457e11b0a1d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a265018be0a630a288cae941ddbed6c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9e2f43501fd9adb011f4d3005ef3a17 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94ae7dbeae526a56fe7f2c90b0e8cf80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa5ba884ec29da284cbb48e415e7b299 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f81150df0b5df7e834b32585d04966e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfe5cb30535b0200041613b71c6ac5a8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9c91ab1095c1cf0ed34acbe3b395394 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7280a9ec75c1a6a9f3c2c331b2842677 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f554072616fab92816d6e87cc2611a47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_660b3d0ed27f4928322dc2921226e290
date	2023-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/s13058-023-01639-y https://pubmed.ncbi.nlm.nih.gov/36998014 https://pubmed.ncbi.nlm.nih.gov/PMC10061837
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21884 https://portal.issn.org/resource/ISSN/1465-542X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low
discusses	http://id.nlm.nih.gov/mesh/M0028859
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D064726Q000628 http://id.nlm.nih.gov/mesh/D064726Q000188 http://id.nlm.nih.gov/mesh/D001943
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D059016Q000235 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D019394
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a93161d0f08c8d6bb60a2c3206bc12d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5531bd923baf81a265e1654f93b7486d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bd949e71951c3e6d4f12c1486c24e296 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e8ad08f759b2798c1b5dca78861cc6ce http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3ae805347053af28ceb0cdf3b4434694

Total number of triples: 51.